Showing results (271-280 of 760) with videos related to

Sort By:
Pageof 76
Blood|May 31, 2002
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implicationsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Oncoimmunology|May 6, 2015
Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cellsJooeun Bae, Mehmet Samur, Aditya Munshi, et al.
Cancer Management and Research|December 29, 2010
Bortezomib in the management of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Teru Hideshima, et al.
British Journal of Haematology|January 11, 2005
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
Leukemia|July 21, 2018
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivityJiye Liu, Tianyu Song, Wenrong Zhou, et al.
Leukemia|June 12, 2019
The effects of MicroRNA deregulation on pre-RNA processing network in multiple myelomaSophia Adamia, Ivane Abiatari, Samir B Amin, et al.
BMC Genomics|October 18, 2014
Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone diseasePaul Dowling, Catriona Hayes, Kay Reen Ting, et al.
Frontiers in Oncology|February 25, 2022
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted TreatmentClaudio Cerchione, Saad Z Usmani, A Keith Stewart, et al.
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Pageof 76